Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immune modulation by aspirin during experimental rhinovirus colds.

× No keyword cloud information.

16 in total

1. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon.

Authors: F G Hayden; J K Albrecht; D L Kaiser; J M Gwaltney
Journal: N Engl J Med Date: 1986-01-09 Impact factor: 91.245

2. Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection.

Authors: F G Hayden; J M Gwaltney
Journal: Antimicrob Agents Chemother Date: 1982-06 Impact factor: 5.191

3. Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha 2.

Authors: F G Hayden; J M Gwaltney
Journal: Antiviral Res Date: 1983-03 Impact factor: 5.970

4. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds.

Authors: F G Hayden; J M Gwaltney
Journal: J Infect Dis Date: 1984-08 Impact factor: 5.226

5. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.

Authors: C R Klimt; G L Knatterud; J Stamler; P Meier
Journal: J Am Coll Cardiol Date: 1986-02 Impact factor: 24.094

Review 6. Alpha interferon in the treatment of hematologic malignancies.

Authors: M S Roth; K A Foon
Journal: Am J Med Date: 1986-11 Impact factor: 4.965

7. Mechanism of action of thymosin. II. Effects of aspirin and thymosin on enhancement of IL-2 production.

Authors: M M Zatz; A Skotnicki; J M Bailey; J H Oliver; A L Goldstein
Journal: Immunopharmacology Date: 1985-06

8. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

Authors: S A Rosenberg; M T Lotze; L M Muul; A E Chang; F P Avis; S Leitman; W M Linehan; C N Robertson; R E Lee; J T Rubin
Journal: N Engl J Med Date: 1987-04-09 Impact factor: 91.245

9. The efficacy and tolerance of intranasal interferons: studies at the Common Cold Unit.

Authors: D A Tyrrell
Journal: J Antimicrob Chemother Date: 1986-10 Impact factor: 5.790

10. Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection.

Authors: A S Monto; T C Shope; S A Schwartz; J K Albrecht
Journal: J Infect Dis Date: 1986-07 Impact factor: 5.226

5 in total

1. Acetylsalicylic acid has no effects on various isolated immune cells in vitro.

Authors: G Uhlenbruck; H Lötzerich; J Bernhardt; K Rogalla
Journal: Eur J Appl Physiol Occup Physiol Date: 1993

2. Influence of acetylsalicylic acid on a Listeria monocytogenes infection.

Authors: S Hockertz; I Paulini; K Rogalla; T Schettler
Journal: Agents Actions Date: 1993-09

Review 3. Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors: Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal: Pulm Pharmacol Ther Date: 2014-11-13 Impact factor: 3.410

Review 4. Aspirin and Infection: A Narrative Review.

Authors: Stefano Di Bella; Roberto Luzzati; Luigi Principe; Verena Zerbato; Elisa Meroni; Mauro Giuffrè; Lory Saveria Crocè; Marco Merlo; Maria Perotto; Elisabetta Dolso; Cristina Maurel; Antonio Lovecchio; Eugenia Dal Bo; Cristina Lagatolla; Bruna Marini; Rudy Ippodrino; Gianfranco Sanson
Journal: Biomedicines Date: 2022-01-25

5. Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC).

Authors: M Jäpel; H Lötzerich; K Rogalla
Journal: Mediators Inflamm Date: 1994 Impact factor: 4.711

5 in total